Fresenius Medical Care (NYSE:FMS) Shares Gap Up - What's Next?

Fresenius Medical Care AG (NYSE:FMS - Get Free Report) gapped up before the market opened on Friday . The stock had previously closed at $21.32, but opened at $21.93. Fresenius Medical Care shares last traded at $21.90, with a volume of 52,465 shares.

Analyst Ratings Changes

Several equities research analysts have issued reports on FMS shares. Truist Financial raised their price objective on shares of Fresenius Medical Care from $22.00 to $23.00 and gave the stock a "hold" rating in a research report on Monday, October 7th. StockNews.com assumed coverage on Fresenius Medical Care in a report on Saturday, November 9th. They issued a "strong-buy" rating on the stock. Finally, Berenberg Bank assumed coverage on Fresenius Medical Care in a research report on Wednesday, November 6th. They set a "buy" rating and a $25.60 price objective on the stock. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, two have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $24.30.

Fresenius Medical Care Price Performance

The company has a fifty day simple moving average of $20.60 and a two-hundred day simple moving average of $20.24. The stock has a market capitalization of $13.02 billion, a price-to-earnings ratio of 18.25, a PEG ratio of 0.97 and a beta of 0.91. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.02 and a current ratio of 1.37.

Institutional Trading of Fresenius Medical Care

Institutional investors and hedge funds have recently made changes to their positions in the company. Allworth Financial LP boosted its holdings in shares of Fresenius Medical Care by 53.1% in the 3rd quarter. Allworth Financial LP now owns 1,675 shares of the company's stock valued at $36,000 after purchasing an additional 581 shares in the last quarter. GAMMA Investing LLC grew its position in Fresenius Medical Care by 50.4% in the third quarter. GAMMA Investing LLC now owns 4,998 shares of the company's stock valued at $106,000 after acquiring an additional 1,675 shares during the last quarter. ORG Wealth Partners LLC acquired a new position in Fresenius Medical Care during the third quarter worth about $112,000. Venturi Wealth Management LLC lifted its holdings in shares of Fresenius Medical Care by 1,045.8% in the third quarter. Venturi Wealth Management LLC now owns 5,259 shares of the company's stock worth $112,000 after acquiring an additional 4,800 shares during the last quarter. Finally, SageView Advisory Group LLC acquired a new stake in shares of Fresenius Medical Care in the 1st quarter valued at approximately $127,000. Institutional investors own 8.25% of the company's stock.

About Fresenius Medical Care

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.